Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Euclid space telescope sees gorgeous cosmic cloud | Space photo of the day for Nov. 18, 2025- Potential Houthi threat to Red Sea shipping could further damage global economy
- 75% of US adults may meet criteria for obesity under new definition, study finds
- Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list
- Discovering a sense of harmony: Individual Accounts of Reflection and Care
- Vote In favor of Your Number one Kind Of Food Conveyance Administration
- How does spider venom damage human cells? Researchers uncover the killer mechanism of recluse spider toxin
- The new queen of country music has no scandals and no gimmicks — and just broke a record set by Taylor Swift
- The Solution to Flexibility: Developing Internal Fortitude Notwithstanding Misfortune
